Omeprazole Accord Healthcare Ireland

Omeprazole, the active ingredient in Omeprazole Accord Healthcare Ireland, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults and children. GNH USA supplies Omeprazole Accord Healthcare Ireland as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Omeprazole Accord Healthcare Ireland as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Omeprazole is a proton pump inhibitor that acts on gastric acid secretion pathways.

- Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Peptic ulcer disease: facilitates ulcer healing by maintaining a less acidic gastric environment. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumours. - Erosive esophagitis: aids healing of erosive damage to the oesophagus. - Helicobacter pylori eradication regimens: used as an adjunct in combination therapy to improve eradication rates.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild and transient. - Diarrhoea: loose stools without blood. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild cramping or discomfort. - Flatulence: increased intestinal gas. - Constipation: infrequent bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhoea. - Fracture risk: decreased calcium absorption may increase risk of hip, wrist or spine fractures with long‑term use. - Vitamin B12 deficiency: malabsorption leading to neuropathy or anaemia. - Acute interstitial nephritis: kidney inflammation presenting with reduced urine output. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.

When using Omeprazole, consider the following precautions:

- Assess renal function: adjust use in severe renal impairment. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Evaluate long‑term use: monitor for bone density loss and vitamin B12 levels. - Pregnancy and lactation: weigh benefits against potential risks; use only if clearly needed. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: decreased absorption leading to sub‑therapeutic levels. - Methotrexate (high dose): increased serum concentrations and toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, requiring more frequent coagulation monitoring. - Digoxin: elevated serum levels may occur, necessitating dose adjustment. - Phenytoin: reduced plasma concentrations, possibly diminishing seizure control.